H-DL-Nle-OMe · HCl

H-DL-Nle-OMe · HCl is a hydrochloride salt of the methyl ester of DL-norleucine (Nle), featuring an amino acid backbone with a side chain that is an unbranched aliphatic methylene sequence and a stereochemical mixture at the α-carbon (DL). The N-terminal amino group is present as a free amine under hydrochloride conditions, while the carboxyl functionality is masked as a methyl ester, which modulates polarity and enables controlled downstream transformations. The ester can participate in peptide coupling strategies after conversion to an activated carboxyl derivative or after hydrolysis to the corresponding acid, whereas the side-chain aliphatic functionality supports derivatization without introducing strongly coordinating heteroatoms. Salt formation improves handling and solubility for synthetic and analytical workflows, positioning the compound as a chiral-independent amino acid ester intermediate for peptide building block preparation and related amino acid derivatization.

1. Peptide Coupling Chemistry

H-DL-Nle-OMe · HCl is applied in peptide synthesis workflows where methyl-ester amino acid derivatives serve as intermediates for generating coupling-ready carboxyl components. The protected carboxyl equivalent (methyl ester) can be converted to an acid or activated as an acylating species, while the free amino group supports standard amide bond formation once appropriate activation and base conditions are selected. The unbranched norleucine side chain provides a hydrophobic residue for constructing peptide fragments and for probing how aliphatic length influences conformational preferences. DL stereochemistry makes the material suitable for library-style synthesis and method development where racemic incorporation is acceptable or where stereochemical resolution is performed later in the route.

2. Protected Amino Acid Synthesis

H-DL-Nle-OMe · HCl is utilized as a starting amino acid ester in protected amino acid chemistry, particularly when downstream N-protection is required for controlled peptide assembly. The amino functionality can be transformed into an N-protected derivative through standard protection strategies, while the methyl ester can be maintained during protection steps to preserve compatibility with iterative coupling schedules. The α-amino acid framework and aliphatic side chain allow straightforward conversion into N-protected norleucine building blocks after ester hydrolysis or activation as needed. The hydrochloride salt form supports practical handling for sequential derivatization, enabling preparation of intermediates used in fine chemical synthesis and peptide building block manufacturing.

3. Amino Acid Derivatization

H-DL-Nle-OMe · HCl is relevant to amino acid derivatization and side-chain functionalization studies where an unbranched aliphatic residue provides a chemically tractable scaffold. The methyl ester can undergo selective hydrolysis to the corresponding carboxylic acid for further coupling chemistry or can be converted into alternative ester forms to tune reactivity and solubility in synthetic sequences. The side chain lacks aromatic or heteroatom substituents, which can simplify chemoselective transformations focused on the backbone functionalities, such as N-functionalization or controlled carboxyl activation. Racemic composition supports exploratory synthesis of analog series and process development for generating downstream norleucine-containing intermediates used in peptide analog construction and chemical biology reagent preparation.

4. SAR Peptidomimetic Building Blocks

H-DL-Nle-OMe · HCl can serve in structure-activity relationship (SAR) and peptidomimetic construction efforts where norleucine residues are incorporated to modulate hydrophobic interactions and backbone packing. The amino acid ester format enables incorporation into synthetic routes that generate amide-linked scaffolds, while the aliphatic side chain provides a tunable hydrophobic element without introducing aromatic π-systems. DL stereochemistry can be leveraged in early-stage analog generation to map tolerance to stereochemical variation, followed by stereodefined synthesis when specific stereochemical effects are identified. The resulting intermediates can feed into iterative scaffold assembly, supporting downstream generation of peptidomimetic libraries and research-grade molecular probes.

5. Pharmaceutical Intermediate Preparation

H-DL-Nle-OMe · HCl is suitable for pharmaceutical intermediate preparation and process chemistry intermediate preparation where amino acid ester handling and conversion to coupling-ready forms are required. The methyl ester and amino hydrochloride combination supports route design that separates ester management from N-functionalization, enabling staged transformations toward norleucine-based fragments used in larger synthetic sequences. The absence of additional reactive side-chain heteroatoms reduces the risk of competing side reactions during backbone-focused steps, which can be advantageous in manufacturing-oriented synthesis planning. The compound's chiral-independent DL character aligns with intermediate supply for processes that either tolerate racemates at an early stage or allow later resolution to the desired stereochemical form.

6. Analytical Standards And Labeling Precursors

H-DL-Nle-OMe · HCl may be employed in analytical research as an amino acid ester reference material and as a precursor for derivative standards used in method development. The hydrochloride salt improves reproducibility in preparation of calibration or derivatization mixtures, while the ester/amine functional set supports conversion to detectable derivatives for chromatographic or mass spectrometric workflows. The norleucine backbone provides a structurally defined aliphatic amino acid motif that can be incorporated into labeled or derivatized analogs for quantification of amino acid ester hydrolysis, peptide fragment analysis, or process monitoring. DL stereochemistry can be acceptable for analytical contexts that quantify total norleucine-derived species rather than enantiomeric composition, supporting robust intermediate characterization across synthetic campaigns.

1. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

2. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

3. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

4. Myotropic activity of allatostatins in tenebrionid beetles

5. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active